174 related articles for article (PubMed ID: 35528020)
1. Impact of RSUME Actions on Biomolecular Modifications in Physio-Pathological Processes.
Fuertes M; Elguero B; Gonilski-Pacin D; Herbstein F; Rosmino J; Ciancio Del Giudice N; Fiz M; Falcucci L; Arzt E
Front Endocrinol (Lausanne); 2022; 13():864780. PubMed ID: 35528020
[TBL] [Abstract][Full Text] [Related]
2. Role of RSUME in inflammation and cancer.
Antico Arciuch VG; Tedesco L; Fuertes M; Arzt E
FEBS Lett; 2015 Nov; 589(22):3330-5. PubMed ID: 26297826
[TBL] [Abstract][Full Text] [Related]
3. Protein stabilization by RSUME accounts for PTTG pituitary tumor abundance and oncogenicity.
Fuertes M; Sapochnik M; Tedesco L; Senin S; Attorresi A; Ajler P; Carrizo G; Cervio A; Sevlever G; Bonfiglio JJ; Stalla GK; Arzt E
Endocr Relat Cancer; 2018 Jun; 25(6):665-676. PubMed ID: 29622689
[TBL] [Abstract][Full Text] [Related]
4. von Hippel-Lindau mutants in renal cell carcinoma are regulated by increased expression of RSUME.
Tedesco L; Elguero B; Pacin DG; Senin S; Pollak C; Garcia Marchiñena PA; Jurado AM; Isola M; Labanca MJ; Palazzo M; Yankilevich P; Fuertes M; Arzt E
Cell Death Dis; 2019 Mar; 10(4):266. PubMed ID: 30890701
[TBL] [Abstract][Full Text] [Related]
5. RSUME, a small RWD-containing protein, enhances SUMO conjugation and stabilizes HIF-1alpha during hypoxia.
Carbia-Nagashima A; Gerez J; Perez-Castro C; Paez-Pereda M; Silberstein S; Stalla GK; Holsboer F; Arzt E
Cell; 2007 Oct; 131(2):309-23. PubMed ID: 17956732
[TBL] [Abstract][Full Text] [Related]
6. RSUME is implicated in HIF-1-induced VEGF-A production in pituitary tumour cells.
Shan B; Gerez J; Haedo M; Fuertes M; Theodoropoulou M; Buchfelder M; Losa M; Stalla GK; Arzt E; Renner U
Endocr Relat Cancer; 2012 Feb; 19(1):13-27. PubMed ID: 22009797
[TBL] [Abstract][Full Text] [Related]
7. Relationship between RSUME and HIF-1α/VEGF-A with invasion of pituitary adenoma.
He W; Huang L; Shen X; Yang Y; Wang D; Yang Y; Zhu X
Gene; 2017 Mar; 603():54-60. PubMed ID: 27989771
[TBL] [Abstract][Full Text] [Related]
8. Expression of RSUME is Associated With Poor Prognosis in Clear Cell Renal Carcinoma: Involvement of ROS Related Metabolism.
Gonilski-Pacin D; Ciancio Del Giudice N; Elguero B; Arzt E
Clin Genitourin Cancer; 2023 Jun; 21(3):393-402.e5. PubMed ID: 37059686
[TBL] [Abstract][Full Text] [Related]
9. RSUME inhibits VHL and regulates its tumor suppressor function.
Gerez J; Tedesco L; Bonfiglio JJ; Fuertes M; Barontini M; Silberstein S; Wu Y; Renner U; Páez-Pereda M; Holsboer F; Stalla GK; Arzt E
Oncogene; 2015 Sep; 34(37):4855-66. PubMed ID: 25500545
[TBL] [Abstract][Full Text] [Related]
10. Mass Spectrometry-Based Metabolic Fingerprinting Contributes to Unveil the Role of RSUME in Renal Cell Carcinoma Cell Metabolism.
Martinefski MR; Elguero B; Knott ME; Gonilski D; Tedesco L; Gurevich Messina JM; Pollak C; Arzt E; Monge ME
J Proteome Res; 2021 Jan; 20(1):786-803. PubMed ID: 33124415
[TBL] [Abstract][Full Text] [Related]
11. In silico structural and functional characterization of the RSUME splice variants.
Gerez J; Fuertes M; Tedesco L; Silberstein S; Sevlever G; Paez-Pereda M; Holsboer F; Turjanski AG; Arzt E
PLoS One; 2013; 8(2):e57795. PubMed ID: 23469069
[TBL] [Abstract][Full Text] [Related]
12. RSUME enhances glucocorticoid receptor SUMOylation and transcriptional activity.
Druker J; Liberman AC; Antunica-Noguerol M; Gerez J; Paez-Pereda M; Rein T; Iñiguez-Lluhí JA; Holsboer F; Arzt E
Mol Cell Biol; 2013 Jun; 33(11):2116-27. PubMed ID: 23508108
[TBL] [Abstract][Full Text] [Related]
13. RSUME is implicated in tumorigenesis and metastasis of pancreatic neuroendocrine tumors.
Wu Y; Tedesco L; Lucia K; Schlitter AM; Garcia JM; Esposito I; Auernhammer CJ; Theodoropoulou M; Arzt E; Renner U; Stalla GK
Oncotarget; 2016 Sep; 7(36):57878-57893. PubMed ID: 27506944
[TBL] [Abstract][Full Text] [Related]
14. Modifications in the cellular proteome and their clinical application.
Elguero B; Gonilski Pacin D; Cárdenas Figueroa C; Fuertes M; Arzt E
Medicina (B Aires); 2019; 79(Spec 6/1):570-575. PubMed ID: 31864228
[TBL] [Abstract][Full Text] [Related]
15. Cytokines and genes in pituitary tumorigenesis: RSUME role in cell biology.
Fuertes M; Gerez J; Haedo M; Giacomini D; Páez-Pereda M; Labeur M; Stalla GK; Arzt E
Front Horm Res; 2010; 38():1-6. PubMed ID: 20616489
[TBL] [Abstract][Full Text] [Related]
16. Hsp90 regulates a von Hippel Lindau-independent hypoxia-inducible factor-1 alpha-degradative pathway.
Isaacs JS; Jung YJ; Mimnaugh EG; Martinez A; Cuttitta F; Neckers LM
J Biol Chem; 2002 Aug; 277(33):29936-44. PubMed ID: 12052835
[TBL] [Abstract][Full Text] [Related]
17. Regulation of STRA13 by the von Hippel-Lindau tumor suppressor protein, hypoxia, and the UBC9/ubiquitin proteasome degradation pathway.
Ivanova AV; Ivanov SV; Danilkovitch-Miagkova A; Lerman MI
J Biol Chem; 2001 May; 276(18):15306-15. PubMed ID: 11278694
[TBL] [Abstract][Full Text] [Related]
18. Up-regulation of hypoxia-inducible factors HIF-1alpha and HIF-2alpha under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function.
Krieg M; Haas R; Brauch H; Acker T; Flamme I; Plate KH
Oncogene; 2000 Nov; 19(48):5435-43. PubMed ID: 11114720
[TBL] [Abstract][Full Text] [Related]
19. Ubiquitin/SUMO modification regulates VHL protein stability and nucleocytoplasmic localization.
Cai Q; Robertson ES
PLoS One; 2010 Sep; 5(9):. PubMed ID: 20844582
[TBL] [Abstract][Full Text] [Related]
20. Hypoxia-induced VEGF production 'RSUMEs' in pituitary adenomas.
Fowkes RC; Vlotides G
Endocr Relat Cancer; 2012 Feb; 19(1):C1-5. PubMed ID: 22009798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]